ATTBF Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume2.00K
Average Volume (3M)N/A
Market Cap
$478.00
Enterprise Value-$429.63B
Total Cash (Recent Filing)$2.40M
Total Debt (Recent Filing)$1.57M
Price to Earnings (P/E)―
Beta14.31
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding477,804,140
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.02
Price to Sales (P/S)31.59
P/FCF Ratio2.59
Enterprise Value/Market Cap-898.81M
Enterprise Value/Revenue-1.20M
Enterprise Value/Gross Profit-1.78M
Enterprise Value/Ebitda148.36K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ATTBF FAQ
What was Abattis Bioceuticals Corp’s price range in the past 12 months?
Currently, no data Available
What is Abattis Bioceuticals Corp’s market cap?
Abattis Bioceuticals Corp’s market cap is $478.00.
When is Abattis Bioceuticals Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Abattis Bioceuticals Corp’s earnings last quarter?
Abattis Bioceuticals Corp released its earnings results on Aug 16, 2019. The company reported -$0.001 earnings per share for the quarter.
Is Abattis Bioceuticals Corp overvalued?
According to Wall Street analysts Abattis Bioceuticals Corp’s price is currently Overvalued.
Does Abattis Bioceuticals Corp pay dividends?
Abattis Bioceuticals Corp does not currently pay dividends.
What is Abattis Bioceuticals Corp’s EPS estimate?
Abattis Bioceuticals Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abattis Bioceuticals Corp have?
Abattis Bioceuticals Corp has 477,804,140 shares outstanding.
What happened to Abattis Bioceuticals Corp’s price movement after its last earnings report?
Abattis Bioceuticals Corp reported an EPS of -$0.001 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Abattis Bioceuticals Corp?
Currently, no hedge funds are holding shares in ATTBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Abattis Bioceuticals Corp
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.